Growing too slow. That said, the growth in revenues may point to increased receipts next quarter. But this was two quarters in a row where receipts growth was stagnant. Not what you want to see from a growing company.
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
